ID

35609

Description

Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- EXtended Antiplatelet Monotherapy (HOST-EXAM); ODM derived from: https://clinicaltrials.gov/show/NCT02044250

Link

https://clinicaltrials.gov/show/NCT02044250

Keywords

Versions (1)
  1. 3/12/19 3/12/19 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

March 12, 2019

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Coronary Heart Disease NCT02044250

English

Eligibility Coronary Heart Disease NCT02044250

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. subject must be at least 20 years of age.
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
2. subject who received dual or triple antiplatelet therapy for 1 year (± 6 months) after drug-eluting stent implantation for coronary artery disease
Description

Antiplatelet therapy Dual | Antiplatelet therapy Triple | Drug-eluting stent placement Coronary Artery Disease

Data type

boolean

Alias
UMLS CUI [1,1]
C1096021
UMLS CUI [1,2]
C0205173
UMLS CUI [2,1]
C1096021
UMLS CUI [2,2]
C0205174
UMLS CUI [3,1]
C4286029
UMLS CUI [3,2]
C1956346
3. subject without clinical events during 1 year (± 6 months)
Description

Event Clinical Absent

Data type

boolean

Alias
UMLS CUI [1,1]
C0441471
UMLS CUI [1,2]
C0205210
UMLS CUI [1,3]
C0332197
4. subject who is confirmed to receive antiplatelet monotherapy (aspirin or clopidogrel)
Description

Antiplatelet therapy | Aspirin | clopidogrel

Data type

boolean

Alias
UMLS CUI [1]
C1096021
UMLS CUI [2]
C0004057
UMLS CUI [3]
C0070166
5. subject is able to verbally confirm understandings of risks, benefits and treatment and he/she or his/her legally authorized representative provides written informed consent prior to any study related procedure.
Description

Comprehension Study Protocol | Informed Consent | Informed Consent Patient Representative

Data type

boolean

Alias
UMLS CUI [1,1]
C0162340
UMLS CUI [1,2]
C2348563
UMLS CUI [2]
C0021430
UMLS CUI [3,1]
C0021430
UMLS CUI [3,2]
C0030701
6. subject is fertile woman and able to verbally confirm using effective methods of contraception
Description

Childbearing Potential Contraceptive methods

Data type

boolean

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C0700589
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. the patient has a known hypersensitivity or contraindication to aspirin or clopidogrel.
Description

Aspirin allergy | Medical contraindication Aspirin | Hypersensitivity Clopidogrel | Medical contraindication Clopidogrel

Data type

boolean

Alias
UMLS CUI [1]
C0004058
UMLS CUI [2,1]
C1301624
UMLS CUI [2,2]
C0004057
UMLS CUI [3,1]
C0020517
UMLS CUI [3,2]
C0070166
UMLS CUI [4,1]
C1301624
UMLS CUI [4,2]
C0070166
2. subject who cannot interrupt to receive antiplatelet drug.
Description

Antiplatelet Agents Discontinue Unable

Data type

boolean

Alias
UMLS CUI [1,1]
C0085826
UMLS CUI [1,2]
C1444662
UMLS CUI [1,3]
C1299582
3. history of bleeding diathesis or known coagulopathy requiring interruption of antiplatelet drugs.
Description

Bleeding tendency | Blood Coagulation Disorders | Requirement Discontinuation Antiplatelet Agents

Data type

boolean

Alias
UMLS CUI [1]
C1458140
UMLS CUI [2]
C0005779
UMLS CUI [3,1]
C1514873
UMLS CUI [3,2]
C1444662
UMLS CUI [3,3]
C0085826
4. an elective intervention or surgical procedure is planned that would necessitate long-term interruption of antiplatelet drugs during the study.
Description

Intervention elective Planned | Elective Surgical Procedure Planned | Requirement Discontinuation Long-term Antiplatelet Agents

Data type

boolean

Alias
UMLS CUI [1,1]
C0184661
UMLS CUI [1,2]
C0439608
UMLS CUI [1,3]
C1301732
UMLS CUI [2,1]
C0206058
UMLS CUI [2,2]
C1301732
UMLS CUI [3,1]
C1514873
UMLS CUI [3,2]
C1444662
UMLS CUI [3,3]
C0443252
UMLS CUI [3,4]
C0085826
5. liver function abnormality or renal failure
Description

Liver Dysfunction | Kidney Failure

Data type

boolean

Alias
UMLS CUI [1]
C0086565
UMLS CUI [2]
C0035078
ast, alt > 3 x unl
Description

Aspartate aminotransferase increased | Alanine aminotransferase increased

Data type

boolean

Alias
UMLS CUI [1]
C0151904
UMLS CUI [2]
C0151905
creatinine > 2.0 mg/dl
Description

Creatinine measurement, serum

Data type

boolean

Alias
UMLS CUI [1]
C0201976
6. non-cardiac co-morbid conditions are present with life expectancy < 2 years.
Description

Comorbidity | Exception Heart Diseases | Life Expectancy

Data type

boolean

Alias
UMLS CUI [1]
C0009488
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0018799
UMLS CUI [3]
C0023671
7. subject who is pregnant, breastfeeding.
Description

Pregnancy | Breast Feeding

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
8. subject who is not suitable to enroll the study decided by investigator
Description

Study Subject Participation Status Inappropriate

Data type

boolean

Alias
UMLS CUI [1,1]
C2348568
UMLS CUI [1,2]
C1548788
Back to the top of the page

Similar models

Eligibility Coronary Heart Disease NCT02044250

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
1. subject must be at least 20 years of age.
boolean
C0001779 (UMLS CUI [1])
Antiplatelet therapy Dual | Antiplatelet therapy Triple | Drug-eluting stent placement Coronary Artery Disease
Item
2. subject who received dual or triple antiplatelet therapy for 1 year (± 6 months) after drug-eluting stent implantation for coronary artery disease
boolean
C1096021 (UMLS CUI [1,1])
C0205173 (UMLS CUI [1,2])
C1096021 (UMLS CUI [2,1])
C0205174 (UMLS CUI [2,2])
C4286029 (UMLS CUI [3,1])
C1956346 (UMLS CUI [3,2])
Event Clinical Absent
Item
3. subject without clinical events during 1 year (± 6 months)
boolean
C0441471 (UMLS CUI [1,1])
C0205210 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,3])
Antiplatelet therapy | Aspirin | clopidogrel
Item
4. subject who is confirmed to receive antiplatelet monotherapy (aspirin or clopidogrel)
boolean
C1096021 (UMLS CUI [1])
C0004057 (UMLS CUI [2])
C0070166 (UMLS CUI [3])
Comprehension Study Protocol | Informed Consent | Informed Consent Patient Representative
Item
5. subject is able to verbally confirm understandings of risks, benefits and treatment and he/she or his/her legally authorized representative provides written informed consent prior to any study related procedure.
boolean
C0162340 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
C0021430 (UMLS CUI [2])
C0021430 (UMLS CUI [3,1])
C0030701 (UMLS CUI [3,2])
Childbearing Potential Contraceptive methods
Item
6. subject is fertile woman and able to verbally confirm using effective methods of contraception
boolean
C3831118 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
Aspirin allergy | Medical contraindication Aspirin | Hypersensitivity Clopidogrel | Medical contraindication Clopidogrel
Item
1. the patient has a known hypersensitivity or contraindication to aspirin or clopidogrel.
boolean
C0004058 (UMLS CUI [1])
C1301624 (UMLS CUI [2,1])
C0004057 (UMLS CUI [2,2])
C0020517 (UMLS CUI [3,1])
C0070166 (UMLS CUI [3,2])
C1301624 (UMLS CUI [4,1])
C0070166 (UMLS CUI [4,2])
Antiplatelet Agents Discontinue Unable
Item
2. subject who cannot interrupt to receive antiplatelet drug.
boolean
C0085826 (UMLS CUI [1,1])
C1444662 (UMLS CUI [1,2])
C1299582 (UMLS CUI [1,3])
Bleeding tendency | Blood Coagulation Disorders | Requirement Discontinuation Antiplatelet Agents
Item
3. history of bleeding diathesis or known coagulopathy requiring interruption of antiplatelet drugs.
boolean
C1458140 (UMLS CUI [1])
C0005779 (UMLS CUI [2])
C1514873 (UMLS CUI [3,1])
C1444662 (UMLS CUI [3,2])
C0085826 (UMLS CUI [3,3])
Intervention elective Planned | Elective Surgical Procedure Planned | Requirement Discontinuation Long-term Antiplatelet Agents
Item
4. an elective intervention or surgical procedure is planned that would necessitate long-term interruption of antiplatelet drugs during the study.
boolean
C0184661 (UMLS CUI [1,1])
C0439608 (UMLS CUI [1,2])
C1301732 (UMLS CUI [1,3])
C0206058 (UMLS CUI [2,1])
C1301732 (UMLS CUI [2,2])
C1514873 (UMLS CUI [3,1])
C1444662 (UMLS CUI [3,2])
C0443252 (UMLS CUI [3,3])
C0085826 (UMLS CUI [3,4])
Liver Dysfunction | Kidney Failure
Item
5. liver function abnormality or renal failure
boolean
C0086565 (UMLS CUI [1])
C0035078 (UMLS CUI [2])
Aspartate aminotransferase increased | Alanine aminotransferase increased
Item
ast, alt > 3 x unl
boolean
C0151904 (UMLS CUI [1])
C0151905 (UMLS CUI [2])
Creatinine measurement, serum
Item
creatinine > 2.0 mg/dl
boolean
C0201976 (UMLS CUI [1])
Comorbidity | Exception Heart Diseases | Life Expectancy
Item
6. non-cardiac co-morbid conditions are present with life expectancy < 2 years.
boolean
C0009488 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0018799 (UMLS CUI [2,2])
C0023671 (UMLS CUI [3])
Pregnancy | Breast Feeding
Item
7. subject who is pregnant, breastfeeding.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Study Subject Participation Status Inappropriate
Item
8. subject who is not suitable to enroll the study decided by investigator
boolean
C2348568 (UMLS CUI [1,1])
C1548788 (UMLS CUI [1,2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial